• AI Can Help Find New Uses for Old Drugs; Advancing Them to Patients Is the Hard Part

    Bio-IT World | Existing medicines may potentially treat many rare diseases, but turning computational predictions into patient impact remains the real test. Every Cure founder David Fajgenbaum weighs in.

    Sep 18, 2026

  • A 1970s Lipid-Lowering Compound May Offer a New Approach to Obesity

    Bio-IT World | Obesity can cause metabolic conditions, including abnormal blood lipid levels, insulin resistance, and diabetes. New research from Science Advances has identified a potential therapeutic candidate for obesity that boosts the body’s metabolic rate: 5-tetradecyloxy-2-furoic acid or TOFA

    Sep 16, 2026

  • A 1970s Lipid-Lowering Compound May Offer a New Approach to Obesity

    Bio-IT World | Obesity can cause metabolic conditions, including abnormal blood lipid levels, insulin resistance, and diabetes. New research from Science Advances has identified a potential therapeutic candidate for obesity that boosts the body’s metabolic rate: 5-tetradecyloxy-2-furoic acid or TOFA

    Sep 16, 2026

  • Lehigh Team Uses Digital Twin of Gut-Brain Axis to Advance Neurostimulation Therapies

    Bio-IT World | AI is reshaping pharmaceutical manufacturing. We see it being used to automate tasks, uncover insights, and optimize quality. By analyzing complex, rich datasets, AI can predict deviations, fine-tune processes, and accelerate routine tasks and documentation, leading to faster production and higher-quality outcomes. Good Manufacturing Practice environments are precise, traceable, and controlled. Yet as operations scale and complexity grow, maintaining GMP standards is increasingly difficult. This is where AI excels.

    Sep 15, 2026